Advertisement

Topics

ProMIS Neurosciences Announces Third Quarter 2017 Results

08:30 EST 13 Nov 2017 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
TORONTO, Ontario and CAMBRIDGE, Massachusetts November 13, 2017 - ProMIS Neurosciences, Inc., a company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced its operational and fina...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "ProMIS Neurosciences Announces Third Quarter 2017 Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...